Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.

Background: Exemestane can prevent breast cancer in postmenopausal women. Because of potential widespread use, we examined the safety of exemestane on bone health.

Methods: In this nested safety substudy of the MAP.

Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.

Background: Although data from studies in animals demonstrated beneficial effects of whole-body vibration (WBV) therapy on bone, clinical trials in postmenopausal women showed conflicting results.

Objective: To determine whether WBV improves bone density and structure.

Design: A 12-month, single-center, superiority, randomized, controlled trial with 3 parallel groups.